Antenatal corticosteroid therapy: A meta-analysis of the randomized trials, 1972 to 1994☆,☆☆
References (84)
Obstetrical attitudes to glucocorticoid treatment for lung maturation: time for a change?
Eur J Obstet Gynaecol Reprod Biol
(1984)- et al.
Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controll trial
J Pediatr
(1991) The argument for prenatal administration of dexamethasone to prevent respiratory distress syndrome
J Pediatr
(1984)- et al.
Perusing the literature: comparison of MEDLINE searching with a Perinatal Trial Database
Control Clin Trials
(1985) - et al.
A register of controlled trials in perinatal medicine
Control Clin Trials
(1986) - et al.
Single dose glucocorticoid for prevention of respiratory distress syndrome
Lancet
(1977) - et al.
The New Zealand study of antepartum glucocorticoid treatment
The NIH multicentre study and miscellaneous clinical trials of antenatal corticosteroid administration
- et al.
Injection of corticosteroids to the mother to prevent neonatal respiratory distress syndrome
Am J Obstet Gynecol
(1978) - et al.
Results of a double-blind controlled study on the use of betamethasone in the prevention of respiratory distress syndrome
Am J Obstet Gynecol
(1980)
Effect of antepartum glucocorticoid administration upon neonatal respiratory distress syndrome and perinatal infection
Am J Obstet Gynecol
(1984)
The effect of antenatal dexamethasone on the prevention of respiratory distress syndrome in preterm gestation with premature rupture of membranes
Am J Obstet Gynecol
(1986)
A randomized placebo-controlled trial of betamethasone for the prevention of respiratory distress syndrome at 24 to 28 weeks' gestation
Am J Obstet Gynecol
(1992)
Amniotic fluid phospholipids after maternal administration of dexamethasone
Am J Obstet Gynecol
(1983)
A comparison of two glucocorticoid regimens for acceleration of fetal lung maturation in premature labor
Am J Obstet Gynecol
(1976)
The effects of betamethasone on maternal cellular resistance to infection
Am J Obstet Gynecol
(1991)
Cardiovascular complications associated with terbutaline treatment for preterm labor
Am J Obstet Gynecol
(1981)
Maternal morbidity associated with isoxuprine and terbutaline tocolysis
Eur J Obstet Gynecol Reprod Biol
(1981)
Beneficial effects of the combined use of prenatal corticosteroids and postnatal surfactant on preterm infants
Am J Obstet Gynecol
(1993)
Prospective randomized study of corticosteroid in the management of premature rupture of the membranes and the premature gestation
Am J Obstet Gynecol
(1981)
Management of prematurely ruptured membranes: a prospective randomized comparison of observation versus steroids and timed delivery
Am J Obstet Gynecol
(1985)
Amniotic fluid phospholipids after maternal administration of dexamethasone
Am J Obstet Gynecol
(1983)
Premature delivery of fetal lambs infused with glucocorticoids
J Endocrinol
(1969)
A controlled trial of antepartum glucocorticoid treatment for prevention of the RDS in premature infants
Pediatrics
(1972)
How obstetricians in the United Kingdom manage preterm labor
Br J Obstet Gynaecol
(1980)
Ten centre trial of artificial surfactant (artificial lung expanding compound) in very premature babies
Br Med J
(1987)
The OSIRIS Trial
Lancet
(1993)
Antenatal corticosteroid administration reduces the incidence of neonatal respiratory distress syndrome
(1992)
Advances in respiratory distress syndrome
Br Med J
(1982)
Corticosteroids prior to preterm delivery
Materials and methods used in synthesizing evidence to evaluate the effects of care during pregnancy and childbirth
Retrospective and prospective identification of unpublished controlled trials: lessons from a survey of obstetricians pediatricians
Pediatrics
(1989)
The active management of preterm labor and its effects on fetal outcome
Aust N Z J Obstet Gynaecol
(1976)
Reduction of incidence and mortality of respiratory distress syndrome by administration of hydrocortisone to the mother
Arch Dis Child
(1976)
Induction of lung maturity in pending premature delivery and scheduled premature delivery
Zentralbl Gynakol
(1977)
Use of betamethasone in management of preterm gestation with premature rupture of membranes
Obstet Gynecol
(1985)
Betamethasone, albuterol, and threatened premature delivery: benefits and risks
Obstet Gynecol
(1982)
Pharmacologic pulmonary maturation in preterm premature rupture of membranes
Am J Obstet Gynecol
(1991)
A multicentric prospective randomized study in premature rupture of membranes (PROM): respiratory and infectious complications in the newborn
Steroid, antibiotic and tocolytic versus no steroid, antibiotic and tocolytic management in patients with preterm PROM at 25–32 weeks
Design and analysis of randomized clinical trials requiring prolonged observation of each patient: 1: introduction and design
Br J Cancer
(1977)
Overview of randomized trials of diuretics in pregnancy
Br Med J
(1985)
Cited by (794)
Antenatal corticosteroid administration is associated with lower risk of severe ROP in preterm twin infants
2024, Early Human DevelopmentSickle cell disease and pregnancy
2023, Presse MedicaleA nomogram to optimize the timing of antenatal corticosteroids in threatened preterm delivery
2023, American Journal of Obstetrics and Gynecology MFMOne vs 2 courses of antenatal corticosteroids in pregnancies at risk of preterm birth: a secondary analysis of the MACS trial
2023, American Journal of Obstetrics and Gynecology MFMBooster course of antenatal corticosteroids after preterm prelabor rupture of membranes: a double-blind randomized trial
2023, American Journal of Obstetrics and Gynecology MFMOxidative stress in newborn kids and does submitted to different antenatal corticosteroid therapy
2023, Small Ruminant Research
- ☆
Funded in part by Trinity College Dublin, the Coombe Women's Hospital, and the National Institute of Child Health and Development. The Cochrane Collaboration is funded by the United Kingdom Department of Health.
- ☆☆
Based on an initial study that appeared in the Brith Journal of Obstetrics and Gynecology 1990;97:11–25 and on an article that appeared in the National Institute of Child Health and Human Development (US). Report of the Consensus Development Conference on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes; 1994 Feb 28–Mar 2; Bethesda, MD. Bethesda (MD): The Institute; 1994 Nov. p.161–205 (NIH publication; No. 95-3784)
Copyright © 1995 Published by Mosby, Inc.